PUBLISHER: SkyQuest | PRODUCT CODE: 1452798
PUBLISHER: SkyQuest | PRODUCT CODE: 1452798
Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
The market is experiencing a surge driven by the growing adoption of mineral supplements to manage chronic conditions prevalent in a significant portion of the population, such as cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical companies are actively engaging in social campaigns to promote healthier lifestyles and supplement usage. For instance, in February 2023, Torrent Pharmaceuticals Ltd launched the TV campaign #BeShelcalStrong, aiming to raise awareness about calcium deficiency and its impact on daily life. The rise in sedentary lifestyles and unhealthy diets has resulted in more people facing nutritional deficiencies, leading to issues like fatigue, weak bones, and compromised immune systems. Government initiatives promoting healthier lifestyles further contribute to market growth. Key players are focusing on innovative product development and exploring exotic ingredients, while the popularity of plant-based products presents additional growth opportunities. Amid the COVID-19 pandemic, mineral supplements witnessed increased demand, as research indicated the virus disproportionately affected individuals with mineral deficiencies. Despite this positive trend, the market faces challenges from counterfeit product sales, driven by economic crises and political conflicts disrupting the supply chain and leading to the proliferation of locally produced, inexpensive items.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global RNA Analysis Market Segmental Analysis
The global RNA analysis market is segmented on the basis of technology, product, application, end - use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global RNA Analysis Market
The pharmaceutical and biotech industries extensively depend on RNA analysis for the advancement of targeted therapies, personalized medicine, and novel drug candidates. This heightened reliance has generated significant demand for RNA analysis techniques within these sectors.
Restraints in the Global RNA Analysis Market
Analyzing RNA sequencing data requires intricate bioinformatics expertise and resources, posing a potential barrier to its widespread adoption in certain environments. The complexity of the process may limit accessibility and implementation in settings where specialized skills and dedicated resources may be scarce.
Market Trends of the Global RNA Analysis Market
The progress in long-read sequencing technologies has empowered the precise sequencing of entire RNA molecules, thereby advancing our comprehension of alternative splicing, isoforms, and intricate gene structures.